Discontinued — last reported Q4 '25

Operating Expenses

Total Lease Cost

Vertex Pharmaceuticals Total Lease Cost remained flat by 0.0% to $64.38M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 27.5%, from $50.50M to $64.38M. Over 2 years (FY 2023 to FY 2025), Total Lease Cost shows an upward trend with a 22.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2019
Last reportedQ4 2025

How to read this metric

A steady or decreasing trend relative to revenue suggests effective management of operational overhead.

Detailed definition

This metric provides the sum of all lease-related expenses, including operating, finance, short-term, and variable lease...

Peer comparison

Equivalent to 'Total Lease Cost' disclosed in the notes to the financial statements for companies following modern lease accounting standards.

Metric ID: is_cvx_total_lease_cost

Historical Data

3 years
 FY'23FY'24FY'25
Value$171.20M$202.00M$257.50M
YoY Change—+18.0%+27.5%
Range$171.20M – $257.50M
CAGR+22.6%
Avg YoY Growth+22.7%
Median YoY Growth+22.7%
Current Streak2+ years growth

Frequently Asked Questions

What is Vertex Pharmaceuticals's total lease cost?
Vertex Pharmaceuticals (VRTX) reported total lease cost of $64.38M in Q4 2025.
How has Vertex Pharmaceuticals's total lease cost changed year-over-year?
Vertex Pharmaceuticals's total lease cost increased by 27.5% year-over-year, from $50.50M to $64.38M.
What is the long-term trend for Vertex Pharmaceuticals's total lease cost?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's total lease cost has grown at a 22.6% compound annual growth rate (CAGR), from $171.20M to $257.50M.
What does total lease cost mean?
The combined total of all lease-related expenses for the reporting period.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.